Skip to main content
TSE:OPS

Opsens Competitors

C$1.98
+0.06 (+3.13 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
C$1.86
C$2.06
50-Day Range
C$1.62
C$2.25
52-Week Range
C$0.59
C$2.36
Volume102,424 shs
Average Volume216,996 shs
Market CapitalizationC$211.15 million
P/E Ratio141.43
Dividend YieldN/A
BetaN/A

Competitors

Opsens (TSE:OPS) Vs. PHO, GPS, PNG, XCT, NSCI, and MDX

Should you be buying OPS stock or one of its competitors? Companies in the industry of "scientific & technical instruments" are considered alternatives and competitors to Opsens, including Photon Control (PHO), BSM Technologies (GPS), Kraken Robotics (PNG), exactEarth (XCT), Nanalysis Scientific (NSCI), and MedX Health (MDX).

Photon Control (TSE:PHO) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, analyst recommendations and risk.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Photon Control and Opsens, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Photon Control00203.00
Opsens00303.00

Opsens has a consensus target price of C$3.13, indicating a potential upside of 57.83%. Given Opsens' higher probable upside, analysts plainly believe Opsens is more favorable than Photon Control.

Profitability

This table compares Photon Control and Opsens' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Photon ControlN/AN/AN/A
OpsensN/AN/AN/A

Earnings and Valuation

This table compares Photon Control and Opsens' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Photon ControlC$64.66 million5.84C$13.60 millionC$0.1327.77
OpsensC$31.37 million6.73C$1.49 millionC$0.01141.43

Photon Control has higher revenue and earnings than Opsens. Photon Control is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Summary

Opsens beats Photon Control on 4 of the 7 factors compared between the two stocks.

BSM Technologies (TSE:GPS) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, analyst recommendations and risk.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for BSM Technologies and Opsens, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BSM Technologies0000N/A
Opsens00303.00

Opsens has a consensus target price of C$3.13, indicating a potential upside of 57.83%.

Profitability

This table compares BSM Technologies and Opsens' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BSM TechnologiesN/AN/AN/A
OpsensN/AN/AN/A

Earnings and Valuation

This table compares BSM Technologies and Opsens' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BSM TechnologiesC$59.95 million0.00C$-20,699,037.00C($0.26)N/A
OpsensC$31.37 million6.73C$1.49 millionC$0.01141.43

Opsens has lower revenue, but higher earnings than BSM Technologies. BSM Technologies is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Summary

Opsens beats BSM Technologies on 4 of the 5 factors compared between the two stocks.

Kraken Robotics (CVE:PNG) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability.

Analyst Ratings

This is a breakdown of current recommendations for Kraken Robotics and Opsens, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Kraken Robotics00103.00
Opsens00303.00

Kraken Robotics presently has a consensus target price of C$1.00, indicating a potential upside of 72.41%. Opsens has a consensus target price of C$3.13, indicating a potential upside of 57.83%. Given Kraken Robotics' higher probable upside, equities research analysts plainly believe Kraken Robotics is more favorable than Opsens.

Profitability

This table compares Kraken Robotics and Opsens' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Kraken RoboticsN/AN/AN/A
OpsensN/AN/AN/A

Earnings & Valuation

This table compares Kraken Robotics and Opsens' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kraken RoboticsC$12.27 million7.93C$-6,041,592.00C($0.04)-16.11
OpsensC$31.37 million6.73C$1.49 millionC$0.01141.43

Opsens has higher revenue and earnings than Kraken Robotics. Kraken Robotics is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Summary

Opsens beats Kraken Robotics on 5 of the 7 factors compared between the two stocks.

exactEarth (TSE:XCT) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability.

Analyst Ratings

This is a breakdown of current recommendations for exactEarth and Opsens, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
exactEarth0000N/A
Opsens00303.00

Opsens has a consensus target price of C$3.13, indicating a potential upside of 57.83%. Given Opsens' higher probable upside, analysts plainly believe Opsens is more favorable than exactEarth.

Profitability

This table compares exactEarth and Opsens' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
exactEarthN/AN/AN/A
OpsensN/AN/AN/A

Earnings & Valuation

This table compares exactEarth and Opsens' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
exactEarthC$20.37 million3.03C$-13,095,770.00C($0.27)-4.72
OpsensC$31.37 million6.73C$1.49 millionC$0.01141.43

Opsens has higher revenue and earnings than exactEarth. exactEarth is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Summary

Opsens beats exactEarth on 7 of the 7 factors compared between the two stocks.

Nanalysis Scientific (CVE:NSCI) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability.

Earnings & Valuation

This table compares Nanalysis Scientific and Opsens' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nanalysis ScientificC$7.87 million3.86C$-3,962,220.00C($0.06)-7.67
OpsensC$31.37 million6.73C$1.49 millionC$0.01141.43

Opsens has higher revenue and earnings than Nanalysis Scientific. Nanalysis Scientific is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Nanalysis Scientific and Opsens' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Nanalysis ScientificN/AN/AN/A
OpsensN/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations for Nanalysis Scientific and Opsens, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nanalysis Scientific0000N/A
Opsens00303.00

Opsens has a consensus target price of C$3.13, indicating a potential upside of 57.83%. Given Opsens' higher probable upside, analysts plainly believe Opsens is more favorable than Nanalysis Scientific.

Summary

Opsens beats Nanalysis Scientific on 7 of the 7 factors compared between the two stocks.

MedX Health (CVE:MDX) and Opsens (TSE:OPS) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability.

Valuation & Earnings

This table compares MedX Health and Opsens' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MedX HealthC$530,066.0049.78C$-3,342,575.00C($0.02)-7.89
OpsensC$31.37 million6.73C$1.49 millionC$0.01141.43

Opsens has higher revenue and earnings than MedX Health. MedX Health is trading at a lower price-to-earnings ratio than Opsens, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares MedX Health and Opsens' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
MedX HealthN/AN/AN/A
OpsensN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings for MedX Health and Opsens, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
MedX Health0000N/A
Opsens00303.00

Opsens has a consensus target price of C$3.13, suggesting a potential upside of 57.83%. Given Opsens' higher probable upside, analysts clearly believe Opsens is more favorable than MedX Health.

Summary

Opsens beats MedX Health on 6 of the 7 factors compared between the two stocks.


Opsens Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
PHO
Photon Control
1.1$3.61+0.6%C$377.73 millionC$64.66 million27.77High Trading Volume
BSM Technologies logo
GPS
BSM Technologies
0.6N/AN/AC$112.36 millionC$59.95 million-5.45
PNG
Kraken Robotics
1.2$0.58+3.4%C$88.31 millionC$12.27 million-16.11
XCT
exactEarth
0.5$1.25+0.8%C$61.77 millionC$20.37 million-4.72
Nanalysis Scientific logo
NSCI
Nanalysis Scientific
0.4$0.46+2.2%C$32.04 millionC$7.87 million-7.67
MDX
MedX Health
0.5$0.15+6.7%C$23.46 millionC$530,066.00-7.89Gap Down
JTC
JEMTEC
0.6$1.75+9.1%C$3.78 millionC$2.42 million10.29Gap Down
ENTREC logo
ENT
ENTREC
0.5N/AN/AC$3.20 millionC$180.27 million-0.17Gap Down
EUO
Eurocontrol Technics Group
0.7$0.03+100.0%C$2.77 millionC$2.70 million-0.27Gap Up
PHO
78790 (PHO.V)
0.9$2.28+0.9%C$0.00N/A0.00
This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.